BioSpace News Archive

Press Releases

Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer

December 11, 2024
·
2 min read
Press Releases

NeuroBiogen Company and Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company enter into Binding Term Sheet for Worldwide License, Along with the Rights to Sublicense for All of KDS2010 indications; Binding Term Sheet Includes Collaboration for Development and Commercialization of Novel Oral Tablet KDS2010 in Ongoing Phase 2 CardioMetabolic and Neurodegenerative Diseases

December 11, 2024
·
9 min read
Press Releases

Curis Announces Additional Data from TakeAim Leukemia Study

December 11, 2024
·
7 min read
Press Releases

On Target Laboratories Appoints Bill Peters as CEO

December 11, 2024
·
3 min read
Press Releases

Biomemory Secures $18 Million in Series A Funding to Revolutionize Data Storage With Molecular Technology

December 11, 2024
·
3 min read
Press Releases

City of Hope Reports Novel Immunotherapy in Clinical Trial Shows Promise for Patients With Relapsed or Difficult to Treat Chronic Lymphocytic Leukemia (CLL)

December 11, 2024
·
5 min read
Press Releases

QuANTUM-Wild Phase 3 Trial of VANFLYTA® Initiated in Patients with Newly Diagnosed FLT3-ITD Negative AML

December 11, 2024
·
15 min read
Press Releases

Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

December 11, 2024
·
12 min read
Press Releases

NeurAxis Inc. Announces FDA 510(k) Clearance of RED for Testing and Evaluation of Patients with Chronic Constipation

December 11, 2024
·
4 min read
Press Releases

ALX Oncology Announces New Data Demonstrating Evorpacept in Combination with Zanidatamab Generates Promising Antitumor Activity in Advanced Breast Cancer

December 11, 2024
·
6 min read